Interventions: Group 1:PD-1 inhibitor by Intravenous infusion;Group 2:Intravenous infusion of PD-1 inhibitor (200mg) and UCBNK cells (5×10E6- 5×10E7/kg) the next day Primary outcome(s): objective remi
Interleukin-27 (IL-27) can partially reduce tumor growth in several animal models, including pros-tate cancer. We describe our findings on the effects of IL-27 gene delivery on prostate cancer cells a
The effects of adipose derived stromal cells (ASCs) were evaluated on tracheal responsiveness and biochemical parameters in guinea pigs model of chronic obstructive pulmonary disease (COPD). Thirty si
Gene-modified cellular therapies carry inherent risks of severe and potentially fatal adverse events, including the expansion of alloreactive cells or malignant transformation due to insertional mutag